Sign in
VNRX Stock Price, Chart, Stats & News
VolitionRX Ltd
Save
VolitionRX Ltd (VNRX) does not currently pay a dividend.
–
Market cap
–
Current P/E
20.83x
Forward P/E
VNRX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 100.00% |
Operating margin | -1542.24% |
Pretax margin | -1566.41% |
Net margin | -1554.31% |
Effective tax rate | – |
ROA | -354.78% |
ROE | 76.82% |
D/E | -0.33x |
Interest coverage ratio | -15.02x |
VNRX valuation
P/E | – |
P/S | 13.32x |
P/B | -0.61x |
P/CF | -1.09x |
P/FCF | -0.99x |
P/OCF | -1.09x |
PEG | -0.12x |
EV multiple | -0.42x |
About
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu. Q Vet, a cancer screening test for dogs and other animals; Nu.
Similar securities
Based on sector and market capitalization
Report issue